EU drug regulator finds link between AstraZeneca vaccine and blood clots
Experts say that, even if a causal link between the vaccine and blood clots is proved, the risks to the general population of getting a serious clot are small compared to the risks of COVID-19.
A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021.(photo credit: REUTERS/MASSIMO PINCA/FILE PHOTO)ByREUTERSUpdated: